Join

Compare · BLCO vs RXST

BLCO vs RXST

Side-by-side comparison of Bausch + Lomb Corporation (BLCO) and RxSight Inc. (RXST): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both BLCO and RXST operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
  • BLCO is the larger of the two at $5.58B, about 25.3x RXST ($220.6M).
  • Over the past year, BLCO is up 36.7% and RXST is down 65.7% - BLCO leads by 102.4 points.
  • BLCO has been more active in the news (14 items in the past 4 weeks vs 2 for RXST).
  • RXST has more recent analyst coverage (25 ratings vs 18 for BLCO).
PerformanceBLCO+36.70%RXST-65.74%
2025-06-02+0.00%2026-05-29
MetricBLCORXST
Company
Bausch + Lomb Corporation
RxSight Inc.
Price
$15.68+0.38%
$5.32-4.40%
Market cap
$5.58B
$220.6M
1M return
+2.08%
-22.17%
1Y return
+36.70%
-65.74%
Industry
Ophthalmic Goods
Ophthalmic Goods
Exchange
NYSE
NASDAQ
IPO
2022
2021
News (4w)
14
2
Recent ratings
18
25
BLCO

Bausch + Lomb Corporation

Bausch + Lomb Corporation operates as an eye health company in Canada and internationally. It operates through three segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that cover the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions. It offers intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.

RXST

RxSight Inc.

RxSight, Inc., a medical technology company, develops light adjustable lens (LAL) to improve uncorrected visual acuity that can be adjusted enhance uncorrected visual acuity after cataract surgery. It also offers RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is based in Aliso Viejo, California.

Latest BLCO

Latest RXST